Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]
Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.Read the original article
Guardado en:
Autores principales: | Omboni S, Malacco E, Mallion J, Volpe M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e7bad196d9a545c6b5c2eb61d5934d8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
por: Omboni S, et al.
Publicado: (2015) -
Correction: Corrigendum: A global reanalysis of storm surges and extreme sea levels
por: Sanne Muis, et al.
Publicado: (2016) -
Statistical methods in recent HIV noninferiority trials: reanalysis of 11 trials.
por: Philippe Flandre
Publicado: (2011) -
Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
por: V.P. Ivanov, et al.
Publicado: (2016) -
Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.
por: Christa Thoene-Reineke, et al.
Publicado: (2011)